Impact of intermittent fasting on health and disease processes

被引:724
作者
Mattson, Mark P. [1 ,2 ]
Longo, Valter D. [3 ,4 ]
Harvie, Michelle [5 ]
机构
[1] NIA, Lab Neurosci, Baltimore, MD 21224 USA
[2] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA
[3] Univ Southern Calif, Longev Inst, Davis Sch Gerontol, Los Angeles, CA 90089 USA
[4] Univ Southern Calif, Dept Biol Sci, Los Angeles, CA 90089 USA
[5] Univ Hosp South Manchester, Genesis Breast Canc Prevent Ctr, Manchester M23 9LT, Lancs, England
关键词
Alzheimer's disease; Blood pressure; Cardiovascular disease; Diabetes; Insulin resistance; Intermittent fasting; Ketone bodies; Obesity; FAT-FREE MASS; DIETARY RESTRICTION; CALORIC RESTRICTION; WEIGHT-LOSS; BODY-WEIGHT; MOUSE MODEL; ENERGY RESTRICTION; LIFE-SPAN; BEHAVIORAL DEFICITS; NEUROTROPHIC FACTOR;
D O I
10.1016/j.arr.2016.10.005
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Humans in modern societies typically consume food at least three times daily, while laboratory animals are fed ad libitum. Overconsumption of food with such eating patterns often leads to metabolic morbidities (insulin resistance, excessive accumulation of visceral fat, etc.), particularly when associated with a sedentary lifestyle. Because animals, including humans, evolved in environments where food was relatively scarce, they developed numerous adaptations that enabled them to function at a high level, both physically and cognitively, when in a food-deprived/fasted state. Intermittent fasting (IF) encompasses eating patterns in which individuals go extended time periods (e.g., 16-48 h) with little or no energy intake, with intervening periods of normal food intake, on a recurring basis. We use the term periodic fasting (PF) to refer to IF with periods of fasting or fasting mimicking diets lasting from 2 to as many as 21 or more days. In laboratory rats and mice IF and PF have profound beneficial effects on many different indices of health and, importantly, can counteract disease processes and improve functional outcome in experimental models of a wide range of age-related disorders including diabetes, cardiovascular disease, cancers and neurological disorders such as Alzheimer's disease Parkinson's disease and stroke. Studies of IF (e.g., 60% energy restriction on 2 days per week or every other day), PF (e.g., a 5 day diet providing 750-1100 kcal) and time-restricted feeding (TRF; limiting the daily period of food intake to 8 h or less) in normal and overweight human subjects have demonstrated efficacy for weight loss and improvements in multiple health indicators including insulin resistance and reductions in risk factors for cardiovascular disease. The cellular and molecular mechanisms by which IF improves health and counteracts disease processes involve activation of adaptive cellular stress response signaling pathways that enhance mitochondrial health, DNA repair and autophagy. PF also promotes stem cell-based regeneration as well as long-lasting metabolic effects. Randomized controlled clinical trials of IF versus PF and isoenergetic continuous energy restriction in human subjects will be required to establish the efficacy of IF in improving general health, and preventing and managing major diseases of aging. Published by Elsevier B.V.
引用
收藏
页码:46 / 58
页数:13
相关论文
共 146 条
[1]   Cardioprotection by intermittent fasting in rats [J].
Ahmet, I ;
Wan, RQ ;
Mattson, MP ;
Lakatta, EG ;
Talan, M .
CIRCULATION, 2005, 112 (20) :3115-3121
[2]   Chronic Alternate-Day Fasting Results in Reduced Diastolic Compliance and Diminished Systolic Reserve in Rats [J].
Ahmet, Ismayil ;
Wan, Ruiqian ;
Mattson, Mark P. ;
Lakatta, Edward G. ;
Talan, Mark I. .
JOURNAL OF CARDIAC FAILURE, 2010, 16 (10) :843-853
[3]   Weight regaining: From statistics and behaviors to physiology and metabolism [J].
Anastasiou, Costas A. ;
Karfopoulou, Eleni ;
Yannakoulia, Mary .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2015, 64 (11) :1395-1407
[4]  
[Anonymous], ONCOTARGET
[5]   Intermittent fasting dissociates beneficial effects of dietary restriction on glucose metabolism and neuronal resistance to injury from calorie intake [J].
Anson, RM ;
Guo, ZH ;
de Cabo, R ;
Iyun, T ;
Rios, M ;
Hagepanos, A ;
Ingram, DK ;
Lane, MA ;
Mattson, MP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (10) :6216-6220
[6]   Preservation of blood glucose homeostasis in slow-senescing somatotrophism-deficient mice subjected to intermittent fasting begun at middle or old age [J].
Arum, Oge ;
Saleh, Jamal K. ;
Boparai, Ravneet K. ;
Kopchick, John J. ;
Khardori, Romesh K. ;
Bartke, Andrzej .
AGE, 2014, 36 (03) :1263-1290
[7]   Age and Energy Intake Interact to Modify Cell Stress Pathways and Stroke Outcome [J].
Arumugam, Thiruma V. ;
Phillips, Terry M. ;
Cheng, Aiwu ;
Morrell, Christopher H. ;
Mattson, Mark P. ;
Wan, Ruiqian .
ANNALS OF NEUROLOGY, 2010, 67 (01) :41-52
[8]   Effect of intensive dietetic interventions on weight and glycaemic control in overweight men with Type II diabetes: a randomised trial [J].
Ash, S ;
Reeves, MM ;
Yeo, S ;
Morrison, G ;
Carey, D ;
Capra, S .
INTERNATIONAL JOURNAL OF OBESITY, 2003, 27 (07) :797-802
[9]   Rapamycin improves motor function, reduces 4-hydroxynonenal adducted protein in brain, and attenuates synaptic injury in a mouse model of synucleinopathy [J].
Bai, Xiang ;
Wey, Margaret Chia-Ying ;
Fernandez, Elizabeth ;
Hart, Matthew J. ;
Gelfond, Jonathan ;
Bokov, Alex F. ;
Rani, Sheela ;
Strong, Randy .
PATHOBIOLOGY OF AGING AND AGE-RELATED DISEASES, 2015, 5 (01)
[10]   Intermittent Fasting Modulation of the Diabetic Syndrome in Streptozotocin-Injected Rats [J].
Belkacemi, Louiza ;
Selselet-Attou, Ghalem ;
Hupkens, Emeline ;
Nguidjoe, Evrard ;
Louchami, Karim ;
Sener, Abdullah ;
Malaisse, Willy J. .
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2012, 2012